APA (7th ed.) Citation

G, Z., C, A., C, M., RM, A., M, D., CD, S., . . . S, M. (2021). Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma. Nature communications, 12(1), 7064. https://doi.org/10.1038/s41467-021-27291-8

Chicago Style (17th ed.) Citation

G, Zoumpoulidou, et al. "Therapeutic Vulnerability to PARP1,2 Inhibition in RB1-mutant Osteosarcoma." Nature Communications 12, no. 1 (2021): 7064. https://doi.org/10.1038/s41467-021-27291-8.

MLA (9th ed.) Citation

G, Zoumpoulidou, et al. "Therapeutic Vulnerability to PARP1,2 Inhibition in RB1-mutant Osteosarcoma." Nature Communications, vol. 12, no. 1, 2021, p. 7064, https://doi.org/10.1038/s41467-021-27291-8.